NKE Form 4: Michelle Peluso Receives 2,619 Restricted Class B Shares
Rhea-AI Filing Summary
Michelle A. Peluso, a Nike, Inc. director, received 2,619 restricted shares of Class B Common Stock on 09/09/2025 under the NIKE, Inc. Stock Incentive Plan. The grant was reported on a Form 4 filed jointly by one reporting person and executed by an attorney-in-fact on 09/11/2025. The transaction shows an acquisition (A) of 2,619 shares at a reported price of $0, increasing Ms. Peluso's beneficial ownership to 32,814 shares. The awarded restricted shares vest in full on the earlier of the next annual meeting of shareholders or the last day of the 12th full calendar month after the grant date.
Positive
- Acquisition disclosed: 2,619 restricted shares of Class B Common Stock were acquired on 09/09/2025.
- No cash paid reported: Transaction price is listed as $0, consistent with a restricted share grant under the Stock Incentive Plan.
- Clear vesting terms: Restrictions lapse in full at the earlier of the next annual meeting or the last day of the 12th full calendar month after grant.
- Post-transaction ownership disclosed: Beneficial ownership increased to 32,814 shares, providing transparency under Section 16 reporting.
Negative
- None.
Insights
TL;DR: Director received a short-term restricted stock award of 2,619 Class B shares that vests by the next annual meeting or within 12 months.
The Form 4 discloses a routine equity award to a board director under Nike's Stock Incentive Plan. The grant is non-cash ($0 listed) and increases reported beneficial ownership to 32,814 Class B shares. The vesting condition—100% lapse at the earlier of the next annual meeting or 12 months—indicates a short-term retention/alignment element typical for director compensation. The filing is informational and does not disclose additional transactions, derivative positions, or changes to long-term incentive structures.
TL;DR: Filing appears complete for the disclosed restricted-share grant and follows Section 16 reporting conventions.
The Form 4 includes required elements: reporting person identity and address, issuer symbol (NKE), transaction date (09/09/2025), transaction code (A(1)), amount acquired (2,619), price ($0), and post-transaction beneficial ownership (32,814). The explanation clarifies the vesting schedule. Signature by an attorney-in-fact is present and dated 09/11/2025. No derivative securities or other dispositions are reported on this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class B Common Stock | 2,619 | $0.00 | -- |
Footnotes (1)
- [object Object]